Drug Target Review2024-09-23T12:00:59
Following high-throughput drug screening of the tumour organoids, an effective FDA-approved treatment was identified.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2023-03-20T13:41:33
Sponsored by Bio-Techne
2026-10-30T07:00:00
Contributor Dr Shi-qi An, Drug Target Review
2025-05-14T14:30:00
Sponsored by Abzena
2026-08-20T08:43:00
Author Dr Daniel Tillett
2023-01-06T10:25:33
Sponsored by Leica Microsystems
Site powered by Webvision Cloud